Are you Mark E. Schulte, M.D.? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileMark E. Schulte, M.D. is a healthcare provider in West Seneca, NY specializing in rheumatology. Mark is also listed as specializing in internal medicine. Medicare claims data shows Mark provided 30,612 services to 543 patients. The services billed most often include injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered), injection, golimumab, 1 mg, for intravenous use, and injection, infliximab, excludes biosimilar, 10 mg. This provider record is associated with NPI 1093973471.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
3615 SENECA ST
West Seneca, NY 14224
Within Rheumatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Autoimmune
Bone
Bone Health
Connective Tissue
Genetic & Connective Tissue
Inflammatory
Joints
Nerve & Tendon
Skin & Soft Tissue
Skin & Vascular
Soft Tissue
Spine & Back
Vascular
Most searched procedures
Consultation
Consultations
Diagnostics & Injections
Education & Support
Imaging
Injections
Lab & Diagnostics
Lab Work
Medication Management
Pain Relief
Regenerative Medicine
30,612 services · 543 patients · 14 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | Procedure | 20610 |
48 | As often as other peers in Rheumatology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
321 | More often than most peers in Rheumatology |
| Administration of chemotherapy into vein, each additional hour | Treatment | 96415 |
147 | More often than most peers in Rheumatology |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
45 | Less often than most peers in Rheumatology |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0129 |
11,250 | More often than most peers in Rheumatology |
| Injection, golimumab, 1 mg, for intravenous use | Drug given | J1602 |
7,650 | Less often than most peers in Rheumatology |
| Injection, infliximab, excludes biosimilar, 10 mg | Drug given | J1745 |
4,791 | As often as other peers in Rheumatology |
| Injection, methylprednisolone acetate, 1 mg | Drug given | J1010 |
3,262 | More often than most peers in Rheumatology |
| Injection, denosumab, 1 mg | Drug given | J0897 |
2,224 | Less often than most peers in Rheumatology |
| Infusion, normal saline solution, 250 cc | Drug given | J7050 |
362 | More often than most peers in Rheumatology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Mark E. Schulte is a rheumatologist in West Seneca, NY. That is the designation recorded for this NPI in the federal registry, where it is listed as “Rheumatology”.
NPI registry
Mark E. Schulte is listed at 3615 Seneca St, West Seneca, NY 14224. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (716) 675-7376. Contact the office directly to confirm availability and scheduling.
NPI registry
Mark E. Schulte's National Provider Identifier is 1093973471. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Mark E. Schulte attended Other, graduating in 2004. This comes from the CMS National Downloadable File.
CMS public data
Mark E. Schulte has 22 years experience. Calculated from a graduation year of 2004, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Mark E. Schulte performs procedures including aspiration and/or injection of fluid from large joint; provides treatments such as administration of chemotherapy into vein, 1 hour or less and administration of chemotherapy into vein, each additional hour, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Mark E. Schulte. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.